Just going over the * article from Sep 2018, it mentioned that with FDA approval our product could sell at $2-5K per tube in the US! Mind blowing. Also interesting that even without approval it could sell as an over the counter product for $50- $100 a tube. Even that would make for a successful company so long as the product has reasonable results - even if by some quirk of the system it didn't receive approval. Nice to know it isn't a total loss make or break situation on the approval alone. Less risky.
50 million Americans with acne. 250m globally. Just think of the permutations... ☺️
Ann: Investor Presentation, page-151
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.015(4.69%) |
Mkt cap ! $707.4M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.0¢ | 31.5¢ | $1.478M | 4.506M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 107150 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 594669 | 9 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
